(Press-News.org) Over-the-counter pain medications work as well or better than opioids after wisdom tooth extraction for both men and women, according to a Rutgers Health-led follow-up to a landmark paper on comparative pain relief.
That first paper on the collective experience of more than 1,800 trial patients found that the combination of ibuprofen and acetaminophen provided better pain relief than hydrocodone with acetaminophen for the first two days after surgery and greater satisfaction over the post-operative period. The new subgroup analysis, published in JAMA Network Open, demonstrated that the results held for both male and female patients.
"We wanted to determine whether the pain medication’s effects were consistent in males and females separately," said Janine Fredericks Younger, an associate professor at Rutgers School of Dental Medicine and lead author of the analysis. "And what we found is that in both subgroups (males and females), the non-opioid was superior for that first day and night, and then no worse than the opioid for the rest of the post-op period."
The trial that produced both papers, funded by an $11 million grant from the National Institutes of Health, compared patients who received 400 milligrams of ibuprofen (Advil, Motrin) combined with 500 milligrams of acetaminophen (Tylenol) against those who got 5 milligrams of hydrocodone with acetaminophen.
The gender-specific analysis was particularly important because women consistently report higher pain levels after surgery, raising questions about whether pain medications work differently for each sex.
"There's obviously different biological mechanisms, different hormones involved," said Cecile Feldman, dean of Rutgers School of Dental Medicine and senior author of both studies. "But results confirm that the analgesic effect for both groups is the same."
The researchers deliberately enrolled equal numbers of men and women from the start, allowing them to conduct robust subgroup analyses. Patients across five universities tracked their pain twice daily for nine days using electronic diaries, rating not just pain but also sleep quality, ability to perform daily activities and overall satisfaction.
On every measure, the over-the-counter combination matched or beat the opioid. Patients taking the non-opioid medications reported better sleep quality and less interference with daily activities. Those who received opioids were twice as likely to call back requesting additional pain medication.
"The results actually came in even stronger than we thought they would," Feldman said. "We expected to find the non-opioid to be non-inferior, so that at least it was no worse than opioids. We were surprised to see that it was actually superior."
Dental procedures are a common entry point for opioid exposure. Dentists wrote more than 8.9 million opioid prescriptions in 2022, ranking among the nation's leading prescribers of the drugs.
"There are studies out there to show that when young people get introduced to opioids, as many have via wisdom tooth extraction, there's an increased likelihood that they'll eventually use them again, and then it can lead to addiction," said Fredericks Younger, noting that opioid overdoses kill more than 80,000 Americans annually.
The research focused on the extraction of impacted wisdom teeth, which requires cutting into gums and sometimes removing bone, making it one of the most painful dental procedures. The Food and Drug Administration uses this as a standard model for testing pain medications because it reliably produces moderate to severe pain for about 48 hours.
Feldman said the results, showing the superiority of the over-the-counter medication to opioids, likely apply to other dental procedures but cannot be automatically generalized to surgeries in other parts of the body. She would like to see similar studies conducted for a range of procedures, particularly those for orthopedic injuries, which frequently result in opioid prescriptions for high school and college athletes.
Despite mounting evidence, many dentists continue writing "just in case" opioid prescriptions for patients who are told to start with over-the-counter medications. The next phase of research will examine why these prescribing patterns persist.
"How can we now, with the evidence and the knowledge that we have, eliminate these prescriptions from being written?" Fredericks Younger said.
The findings align with American Dental Association recommendations to avoid opioids as first-line pain treatment. Feldman said the study's results leave little room for doubt.
"We feel pretty confident in saying that opioids should not be prescribed routinely for dental procedures," she said. "Our non-opioid combination really should be the analgesic choice."
END
Non-prescription pain meds work equally well for men and women after tooth extraction
2025-11-06
ELSE PRESS RELEASES FROM THIS DATE:
Mifepristone access through community pharmacies when regulated as a routine prescription medication
2025-11-06
About The Study: The results of this study of pharmacies in British Columbia, Canada, suggest that when medication abortion is available as a routine health service and mifepristone is regulated as a routine prescription, pharmacists play a key role in providing geographically distributed access to medication abortion. These findings may inform policy and initiatives to enhance pharmacist referral networks and improve mifepristone access, as well as service planning for international jurisdictions considering a similar medication abortion ...
UBC study shows good B.C. abortion pill access, but gaps remain
2025-11-06
Most pharmacies in British Columbia can provide the abortion pill mifepristone within days, but uneven access still leaves some women facing barriers to this time-sensitive medication, according to new research.
The study, published Nov. 6 in JAMA Network Open, offers the first province-wide look at pharmacy-level access to mifepristone in B.C.
Mifepristone is used for medical abortions and can be prescribed across Canada by any physician or nurse practitioner and filled at community pharmacies. Initially available only from pharmacists who had completed a training module and pharmacies registered with the manufacturer, Health Canada removed these requirements ...
Researchers find that adaptive music technologies enhance exercise engagement and enjoyment
2025-11-06
Researchers from University of Jyväskylä have found that personalized interactive music systems – smart technologies that adapt rhythm and tempo to users’ movements – can make exercise more enjoyable and help people stay active longer.
These systems, known as PIMSs, use real-time data from wearables and smartphones to adjust musical features such as beat, tempo, and style to match the user’s pace – whether walking, cycling or lifting weights.
For example, when the systems detects you speeding up, it raises the music’s tempo to match your ...
Meditation retreat rapidly reprograms body and mind
2025-11-06
Researchers at the University of California San Diego have found that an intensive retreat combining multiple mind-body techniques, including meditation and healing practices, produced rapid and wide-ranging changes in brain function and blood biology. The researchers found that the retreat engaged natural physiological pathways promoting neuroplasticity, metabolism, immunity and pain relief. The findings, published in Communications Biology, provide insights into how consciousness and psychological practices can enhance physical health.
Meditation and other mind-body practices ...
Biohub launches first large-scale scientific initiative combining Frontier AI with Frontier Biology to cure or prevent disease
2025-11-06
Mark Zuckerberg and Priscilla Chan today announced the launch of a first-of-its-kind initiative combining frontier artificial intelligence and frontier biology to dramatically accelerate scientific progress toward understanding and addressing human disease.
Since its founding in 2016, Biohub’s multidisciplinary teams of scientists and engineers have developed groundbreaking technologies to observe, measure, and program biology at the cellular level. The organization has built the largest single-cell datasets and established large-scale compute ...
High-impact clinical trials generate promising results for improving kidney health - part 1
2025-11-06
The nonsteroidal mineralocorticoid receptor antagonist finerenone has been shown to reduce the risks of major clinical kidney and cardiovascular outcomes in individuals with chronic kidney disease (CKD) and type 2 diabetes. In the phase 3 FINE-ONE trial, investigators assessed the efficacy and safety of finerenone in people with CKD and type 1 diabetes, a patient population that has not had new therapies in the last 30 years. FINE-ONE randomized 242 patients to finerenone or placebo. “The study used albuminuria change over 6 months of treatment as endpoint and bridging biomarker to translate evidence of long-term kidney protective effects from type 2 diabetes and CKD ...
New hope for treating kidney disease in type 1 diabetes
2025-11-06
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction indicates that the degree of kidney damage is reduced and that the drug has a protective effect on kidney function.
Clinical pharmacologist Hiddo Lambers Heerspink of the UMCG led a large international study into the effect of this drug. He will present the initial results of this study at the American Society of Nephrology conference in Houston, where he will present the results during the plenary ...
Populist parties choose divisive issues on purpose, researchers say
2025-11-06
Election researchers from across Europe have looked at how populist parties profile themselves on Facebook. Their findings are quite clear.
"Populist parties much more often use controversial, divisive issues when they want to show themselves to potential voters," says Melanie Magin, a professor of media sociology at the Norwegian University of Science and Technology (NTNU's) Department of Sociology and Political Science.
Magin and her fellow researchers believe this is probably quite deliberate in order to get the debate into a track that these parties believe they benefit from.
The elections to the European Parliament ...
Hollings researcher co-leads AACR subcommittee calling for nicotine limits
2025-11-06
The American Association for Cancer Research (AACR) has endorsed a federal policy that would make cigarettes far less addictive. The proposed policy by the Food and Drug Administration (FDA) sets a maximum nicotine product standard, limiting nicotine levels in combustible cigarettes and related tobacco products to 0.7 milligrams per gram (mg/g) – about 95% less than what is currently allowed. That reduction would make cigarettes minimally or nonaddictive, striking at the chemical that keeps people hooked. The AACR policy statement is published in Clinical Cancer Research.
Leading the policy statement ...
New study links gut microbes to common heart disease
2025-11-06
Key Points:
Cardiovascular diseases are the leading cause of death worldwide.
Gut microbes likely play a role in coronary artery disease (CAD), a common heart disease, but the mechanisms remain largely unknown.
Researchers in Seoul recently identified 15 bacterial species associated with CAD.
The analysis reveals multiple pathways linked to disease severity, including increased inflammation and metabolic imbalance.
Washington, D.C.— Nearly 20 million people die every year from cardiovascular diseases, the leading cause of death worldwide. Genetic ...